Source briefing
HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 November 2026 to 13 November 2026
HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 November 2026 to 13 November 2026
Read →Source briefing
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 18, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 12, Status: Authorised
Read →
Source briefing
Pakistan Moves to Expel Afghan Medical Students
Click to expand Image King Edward Medical University, Lahore, Pakistan. © 2014 Razaawais141/Wikimedia Without warning, Pakistan has directed all medical and dental institutions to expel Afghan students and arrange to send them back to Afghanistan. It is the latest…
Read →
Source briefing
Has pancreatic cancer met its match?
Frontline researcher sees newly approved medication as ‘critical first step’ toward transformation of care
Read →Source briefing
Expert panel support for orphan medical devices
Expert panel support for orphan medical devices
Read →Source briefing
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion
Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion
Read →Source briefing
ECDC Public Health Emergency Preparedness Assessment for Liechtenstein, 2026
This report presents the findings and recommendations of the first assessment conducted in Liechtenstein.
Read →